Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23009dce82e8e911dcbb1c46d2bd86a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f351275614aee851d036b3831e265a7f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate |
2007-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e245785c86745eb3b07becc13271892 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dad3db5fa5de82ede059b7db9e3fb9b |
publicationDate |
2009-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008070460-A9 |
titleOfInvention |
The use of soluble e-cadherin as a novel serum marker |
abstract |
The invention provides a method of assessing the level of an activated form of a cell survival-related signaling molecule. This method entails assaying a biological sample for soluble E-cadherin (SECAD), wherein the level of SECAD is positively correlated with the level of the activated form of the cell survival-related signaling molecule. Also provided are SECAD polypeptides, antibodies, and related test kits. |
priorityDate |
2006-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |